REVIEW PAPER
The importance of acute-phase proteins as markers in cancers
1
Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland
2
Department Historical and Educational Sciences, Institute of Psychology, University of Wroclaw, Warsaw, Poland
3
Institute of Psychology, Pedagogical University, Krakow, Poland
Submission date: 2021-05-05
Final revision date: 2021-08-22
Acceptance date: 2021-12-08
Publication date: 2021-12-31
Medical Studies 2021;37(4):344-348
KEYWORDS
TOPICS
ABSTRACT
Acute-phase proteins (APPs) form a group of heterogeneous proteins whose synthesis takes place in the liver. This involves mediators such as cytokines and constitutes a response to acute inflammations, bacterial infections, tumours, and autoimmune diseases. C-reactive protein is among the most important APPs. It participates in cancerous processes, especially in colon and rectal cancer. Another APP is haptoglobin. This glycoprotein prevents iron loss and kidney damage, and is associated with diagnostic neoplastic progression connected with fucosylation. Fucoso–haptoglobin is a highly effective marker for prognosis because an increased concentration of this complex is indicative of the distant metastases amount. Another APP is acidic -glycoprotein (AGP), which increases to a serious level during acute inflammations and tumour-promoting processes. Its protective role involves platelet aggregation inhibition and chemotactic activity. The purpose of this study was to review the role of selected acute phase proteins in cancer promotion and progression.
REFERENCES (31)
1.
Reczyńska D, Zalewska M, Czopowicz M, Kaba J, Zwierzchowski L, Bagnicka E. Acute phase protein levels as an auxiliary tool in diagnosing viral diseases in ruminants – a review. Viruses 2018; 10: 502.
2.
Miller LL, Bly CG, Watson ML, Bale WF. The dominant role of the liver in plasma protein synthesis: a direct study of the isolated perfused rat liver with the aid of lysine--C14. J Exp Med 1951; 94: 431.
3.
Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 2011; 3: 118-127.
4.
Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005; 6: 1045-1056.
5.
Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-. Pharmacol Therap 2003; 98: 257-265.
6.
Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci 2008; 13: 5094-5107.
7.
Nehring SM, Goyal A, Bansal P, Patel BC. C-Reactive Protein. In StatPearls. StatPearls Publishing 2021.
8.
Pathak A, Agrawal A. Evolution of C-reactive protein. Front Immunol 2019; 10: 943.
9.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9: 754.
10.
Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Commun Health 2007; 61: 824-833.
11.
Mannello F, Tonti GA, Simone P, Ligi D, Medda V. Iron-binding proteins and C-reactive protein in nipple aspirate fluids: role of Iron-driven inflammation in breast cancer microenvironment? Am J Transl Res 2010; 3: 100-113.
12.
Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 2000; 23: 263-266.
13.
Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review. PLoS One 2015; 10: e0143080.
14.
Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, Kim SY, Park SC, Choi HS, Oh JH. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol 2013; 20: 2908-2913.
15.
McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-886.
16.
Naryzhny SN, Legina OK. Haptoglobin as a biomarker. Biomeditsinskaya Khimiya 2021; 67: 105-118.
17.
Shu H, Zhang L, Chen Y, Guo Y, Li L, Chen F, Cao Z, Yan G, Lu C, Liu C, Zhang S. Quantification of intact O-glycopeptides on haptoglobin in sera of patients with hepatocellular carcinoma and liver cirrhosis. Front Chem 2021; 9: 705341.
18.
Lairson LL, Henrissat B, Davies GJ, Withers SG. Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 2008; 77: 521-555.
19.
Carlsson MC, Cederfur C, Schaar V, Balog CI, Lepur A, Touret F, Leffler H. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PLoS One 2011; 6: e26560.
20.
Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N, Miyoshi E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 2008; 122: 2301-2309.
21.
Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008; 143: 725-729.
22.
Dempsey E, Rudd PM. Acute phase glycoproteins: bystanders or participants in carcinogenesis? Ann N York Acad Sci 2012; 1253: 122-132.
23.
He Z, Aristoteli LP, Kritharides L, Garner B. HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation. Biochem Biophys Res Commun 2006; 343: 496-503.
24.
Zhu J, Lin Z, Wu J, Yin H, Dai J, Feng Z, Lubman DM. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res 2014; 13: 2986-2997.
25.
Váradi C, Mittermayr S, Szekrényes Á, Kádas J, Takacs L, Kurucz I, Guttman A. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis. Electrophoresis 2013; 34: 2287-2294.
26.
Takeda Y, Shinzaki S, Okudo K, Moriwaki K, Murata K, Miyoshi E. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012; 118: 3036-3043.
27.
Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol 2009; 50: 592-603.
28.
Bekesova S, Kosti O, Chandler KB, Wu J, Madej HL, Brown KC, Simonyan V, Goldman R. N-glycans in liver-secreted and immunoglogulin-derived protein fractions. J Proteom 2012; 75: 2216-2224.
29.
Schmid K. Preparation and properties of serum and plasma proteins. XXIX. Separation from human plasma of polysaccharides, peptides and proteins of low molecular weight. Crystallization of an acid glycoprotein1a, b, c. J Am Chem Soc 1953; 75: 60-68.
30.
Weimer HE, Mehl JW, Winzler RJ. Studies on the mucoproteins of human plasma: V. Isolation and characterization of a homogeneous mucoprotein. J Biol Chem 1950; 185: 561-568.
31.
Hochepied T, Van Molle W, Berger F, Baumann H, Libert C. Involvement of the acute phase protein 1-acid glycoprotein in nonspecific resistance to a lethal Gram-negative infection. J Biol Chem 2000; 275: 14903-14909.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
